DSP-2230

CAS No. 1233231-30-5

DSP-2230( —— )

Catalog No. M23409 CAS No. 1233231-30-5

DSP-2230 is a selective blocker of Nav1.7/Nav1.8.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 61 In Stock
10MG 101 In Stock
25MG 217 In Stock
50MG 346 In Stock
100MG 554 In Stock
200MG 788 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DSP-2230
  • Note
    Research use only, not for human use.
  • Brief Description
    DSP-2230 is a selective blocker of Nav1.7/Nav1.8.
  • Description
    DSP-2230 is a selective blocker of Nav1.7/Nav1.8.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Nav1.7 channel|Nav1.8 channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1233231-30-5
  • Formula Weight
    419.4
  • Molecular Formula
    C20H20F3N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (298.04 mM; Need ultrasonic)
  • SMILES
    C[C@H](C(N)=O)NCc(n1C2CCC2)nc(cc2)c1nc2Oc(cc1F)cc(F)c1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bagal SK, et al. Voltage gated sodium channels as drug discovery targets. Channels (Austin). 2015;9(6):360-6.
molnova catalog
related products
  • Bulleyaconi cine A

    Bulleyaconitine A is an analgesic and antiinflammatory drug isolated from Aconitum plants; has several potential targets, including voltage-gated Na+ channels.

  • BI-9627

    BI-9627 is a selective and potent sodium hydrogen exchange isomer 1 (NHE1) inhibitor.BI-9627 partially reverses the effects of DMA with IC50 values of 6 and 31 nM in the intracellular pH recovery (pHi) and human platelet lysis assays.

  • Zandatrigine

    Zandatrigine (NBI-921352) is a sodium channel protein type 8 subunit alpha blocker, suitable for studies on epilepsy treatment and nervous system pathologies.